Adipose-Derived Stem Cells for Regenerative Medicine

Paper

Abstract

The emerging field of regenerative medicine will require a reliable source of stem cells in addition to biomaterial scaffolds and cytokine growth factors. Adipose tissue represents an abundant and accessible source of adult stem cells with the ability to differentiate along multiple lineage pathways. The isolation, characterization, and preclinical and clinical application of adipose-derived stem cells (ASCs) are reviewed in this article.

Analysis

Paper intelligence

Summary

This review explores adipose-derived stem cells (ASCs) as a promising source for regenerative medicine, detailing their isolation, characterization, and applications.

Key findings

Adipose tissue is an abundant and accessible source of adult stem cells.
ASCs possess multipotent differentiation capabilities.
ASCs have preclinical and clinical applications in regenerative medicine.

Methods

Review of isolation and characterization of ASCs.
Discussion of preclinical and clinical applications of ASCs.

Applications

Regenerative medicine
Tissue engineering

Confidence100%

Discovery

Related papers

2026Crossref1 citations

From monolayer to organoids and multi-organ microphysiological systems: advancing regenerative medicine and precision therapies

Mahmood S. Choudhery; Ahmad Niaz; Taqdees Arif; Ruhma Mahmood

Jul 2, 2026Stem Cell Research & Therapy

2026Crossref0 citations

Intraosseous therapy: harnessing the potential of tissue regeneration and repair

Mikhail Yu. Artamonov; Inessa A. Minenko

May 8, 2026Frontiers in Medicine

2026PubMed

Chondroitin Sulfate as a Bioactive Carbohydrate: Design of Nanoplatforms for Drug Delivery, Tissue Engineering, and Disease Therapy.

Shabbir A; Parvinzadeh Gashti M

Jan 1, 2026ACS applied bio materials

2026PubMed

Natural Polymer-Based Scaffolds for Bone Tissue Engineering: A Review of Materials, Function, and Translation.

Huang Z; Zhao H; Xia Z; Wang J; Cai K

Jan 1, 2026ACS biomaterials science & engineering

2026PubMed

Engineered mesenchymal stem cell-derived extracellular vesicles as programmable biomaterial platforms for liver fibrosis: design principles, manufacturing and clinical translation.

Wang F; Zhu K; Zhu X; Yao J; Sun Z; Li X

Jan 1, 2026Frontiers in bioengineering and biotechnology

2026PubMed

Secondary failure of platelet recovery after allogeneic hematopoietic stem cell transplantation in pediatric acquired aplastic anemia: Incidence, risk factors, and clinical outcomes.

Shang Y; Ren Y; Liu L; Wang X; Jiang C; Chen X; Wan Y; Zhang A; Zhang X; Liu F; Zhang L; Chen Y; Zou Y; Chen X; Yang W; Zhu X; Guo Y

Jan 1, 2026Clinical hematology international

Source record

Publication metadata

Authors: Jeffrey M. Gimble; Adam J. Katz; Bruce A. Bunnell
Published: May 10, 2007
Journal or venue: Circulation Research
DOI: 10.1161/01.res.0000265074.83288.09
Paper type: journal article
Source: Openalex

DOI OpenAlex